XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Impact of adopting ASC 326
Total stockholders' equity attributable to parent
Total stockholders' equity attributable to parent
Impact of adopting ASC 326
Common stock
Additional paid-in capital
Retained earnings
Retained earnings
Impact of adopting ASC 326
Accumulated other comprehensive income (loss)
Treasury stock
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2021         12,934,966            
Beginning balance (in shares) at Dec. 31, 2021                   848,016  
Beginning balance at Dec. 31, 2021 $ 275,303   $ 274,328   $ 12,935 $ 143,521 $ 138,219   $ (3,606) $ (16,741) $ 975
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 2,671   2,864       2,864       (193)
Other comprehensive income (loss) (13,556)   (13,556)           (13,556)    
Dividends on common stock (2,059)   (2,059)       (2,059)        
Stock-based compensation 674   674     674          
Stock-based compensation related to equity method investment 104   104     104          
Common stock options exercised (in shares)         56,174            
Common stock options exercised 725   725   $ 56 669          
Ending balance (in shares) at Mar. 31, 2022         12,991,140            
Ending balance (in shares) at Mar. 31, 2022                   848,016  
Ending balance at Mar. 31, 2022 263,862   263,080   $ 12,991 144,968 139,024   (17,162) $ (16,741) 782
Beginning balance (in shares) at Dec. 31, 2021         12,934,966            
Beginning balance (in shares) at Dec. 31, 2021                   848,016  
Beginning balance at Dec. 31, 2021 275,303   274,328   $ 12,935 143,521 138,219   (3,606) $ (16,741) 975
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 8,017                    
Other comprehensive income (loss) (36,371)                    
Ending balance (in shares) at Sep. 30, 2022         13,134,951            
Ending balance (in shares) at Sep. 30, 2022                   848,016  
Ending balance at Sep. 30, 2022 244,360   243,913   $ 13,135 146,950 140,546   (39,977) $ (16,741) 447
Beginning balance (in shares) at Mar. 31, 2022         12,991,140            
Beginning balance (in shares) at Mar. 31, 2022                   848,016  
Beginning balance at Mar. 31, 2022 263,862   263,080   $ 12,991 144,968 139,024   (17,162) $ (16,741) 782
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 2,791   2,956       2,956       (165)
Other comprehensive income (loss) (12,258)   (12,258)           (12,258)    
Dividends on common stock (2,076)   (2,076)       (2,076)        
Stock-based compensation 757   757     757          
Stock-based compensation related to equity method investment 173   173     173          
Common stock options exercised (in shares)         30,200            
Common stock options exercised 392   392   $ 30 362          
Restricted stock units vested (in shares)         73,300            
Restricted stock units vested 0   0   $ 73 (73)          
Minimum tax withholding on restricted stock units issued (in shares)         (17,596)            
Minimum tax withholding on restricted stock units issued (691)   (691)   $ (17) (674)          
Stock purchase from noncontrolling interest (40)   (33)     (33)         (7)
Ending balance (in shares) at Jun. 30, 2022         13,077,044            
Ending balance (in shares) at Jun. 30, 2022                   848,016  
Ending balance at Jun. 30, 2022 252,910   252,300   $ 13,077 145,480 139,904   (29,420) $ (16,741) 610
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 2,555   2,718       2,718       (163)
Other comprehensive income (loss) (10,557)   (10,557)           (10,557)    
Dividends on common stock (2,076)   (2,076)       (2,076)        
Stock-based compensation 671   671     671          
Stock-based compensation related to equity method investment 139   139     139          
Common stock options exercised (in shares)         55,853            
Common stock options exercised 718   718   $ 56 662          
Restricted stock units vested (in shares)         2,054            
Restricted stock units vested 0   0   $ 2 (2)          
Ending balance (in shares) at Sep. 30, 2022         13,134,951            
Ending balance (in shares) at Sep. 30, 2022                   848,016  
Ending balance at Sep. 30, 2022 $ 244,360   243,913   $ 13,135 146,950 140,546   (39,977) $ (16,741) 447
Beginning balance (in shares) at Dec. 31, 2022 12,618,265       13,466,281            
Beginning balance (in shares) at Dec. 31, 2022 848,016                 848,016  
Beginning balance at Dec. 31, 2022 $ 261,391 $ (6,642) 261,084 $ (6,642) $ 13,466 157,152 144,911 $ (6,642) (37,704) $ (16,741) 307
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 11,220   11,342       11,342       (122)
Other comprehensive income (loss) 6,766   6,766           6,766    
Dividends on common stock (2,146)   (2,146)       (2,146)        
Stock-based compensation 831   831     831          
Stock-based compensation related to equity method investment 69   69     69          
Common stock options exercised (in shares)         4,450            
Common stock options exercised 70   70   $ 4 66          
Restricted stock units vested (in shares)         43,882            
Restricted stock units vested 0   0   $ 44 (44)          
Minimum tax withholding on restricted stock units issued (in shares)         (13,416)            
Minimum tax withholding on restricted stock units issued (243)   (243)   $ (13) (230)          
Ending balance (in shares) at Mar. 31, 2023         13,501,197            
Ending balance (in shares) at Mar. 31, 2023                   848,016  
Ending balance at Mar. 31, 2023 $ 271,316   271,131   $ 13,501 157,844 147,465   (30,938) $ (16,741) 185
Beginning balance (in shares) at Dec. 31, 2022 12,618,265       13,466,281            
Beginning balance (in shares) at Dec. 31, 2022 848,016                 848,016  
Beginning balance at Dec. 31, 2022 $ 261,391 $ (6,642) 261,084 $ (6,642) $ 13,466 157,152 144,911 $ (6,642) (37,704) $ (16,741) 307
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 23,090                    
Other comprehensive income (loss) $ (2,547)                    
Ending balance (in shares) at Sep. 30, 2023 12,726,223       13,574,239            
Ending balance (in shares) at Sep. 30, 2023 848,016                 848,016  
Ending balance at Sep. 30, 2023 $ 271,369   271,416   $ 13,574 159,717 155,117   (40,251) $ (16,741) (47)
Beginning balance (in shares) at Mar. 31, 2023         13,501,197            
Beginning balance (in shares) at Mar. 31, 2023                   848,016  
Beginning balance at Mar. 31, 2023 271,316   271,131   $ 13,501 157,844 147,465   (30,938) $ (16,741) 185
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 7,998   8,112       8,112       (114)
Other comprehensive income (loss) (3,526)   (3,526)           (3,526)    
Dividends on common stock (2,163)   (2,163)       (2,163)        
Stock-based compensation 792   792     792          
Stock-based compensation related to equity method investment 104   104     104          
Common stock options exercised (in shares)         3,000            
Common stock options exercised 43   43   $ 3 40          
Restricted stock units vested (in shares)         86,520            
Restricted stock units vested 0   0   $ 87 (87)          
Minimum tax withholding on restricted stock units issued (in shares)         (22,878)            
Minimum tax withholding on restricted stock units issued (438)   (438)   $ (23) (415)          
Stock purchase from noncontrolling interest 171   294     294         (123)
Ending balance (in shares) at Jun. 30, 2023         13,567,839            
Ending balance (in shares) at Jun. 30, 2023                   848,016  
Ending balance at Jun. 30, 2023 274,297   274,349   $ 13,568 158,572 153,414   (34,464) $ (16,741) (52)
Increase (Decrease) in Stockholders' Equity                      
Net income (loss) 3,872   3,867       3,867       5
Other comprehensive income (loss) (5,787)   (5,787)           (5,787)    
Dividends on common stock (2,164)   (2,164)       (2,164)        
Stock-based compensation 949   949     949          
Stock-based compensation related to equity method investment 104   104     104          
Common stock options exercised (in shares)         6,400            
Common stock options exercised $ 98   98   $ 6 92          
Ending balance (in shares) at Sep. 30, 2023 12,726,223       13,574,239            
Ending balance (in shares) at Sep. 30, 2023 848,016                 848,016  
Ending balance at Sep. 30, 2023 $ 271,369   $ 271,416   $ 13,574 $ 159,717 $ 155,117   $ (40,251) $ (16,741) $ (47)